Regence and TRHC collaborate on Covid-19 virtual clinical trial
The trial will also examine the combined risk of increased ADEs for drug regimens with Covid-19 repurposed adjuvants. Credit: Regence.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more